PLoS ONE (Jan 2019)

Cardiovascular risk prediction models for women in the general population: A systematic review.

  • Sara J Baart,
  • Veerle Dam,
  • Luuk J J Scheres,
  • Johanna A A G Damen,
  • René Spijker,
  • Ewoud Schuit,
  • Thomas P A Debray,
  • Bart C J M Fauser,
  • Eric Boersma,
  • Karel G M Moons,
  • Yvonne T van der Schouw,
  • CREW consortium

DOI
https://doi.org/10.1371/journal.pone.0210329
Journal volume & issue
Vol. 14, no. 1
p. e0210329

Abstract

Read online

AimTo provide a comprehensive overview of cardiovascular disease (CVD) risk prediction models for women and models that include female-specific predictors.MethodsWe performed a systematic review of CVD risk prediction models for women in the general population by updating a previous review. We searched Medline and Embase up to July 2017 and included studies in which; (a) a new model was developed, (b) an existing model was validated, or (c) a predictor was added to an existing model.ResultsA total of 285 prediction models for women have been developed, of these 160 (56%) were female-specific models, in which a separate model was developed solely in women and 125 (44%) were sex-predictor models. Out of the 160 female-specific models, 2 (1.3%) included one or more female-specific predictors (mostly reproductive risk factors). A total of 591 validations of sex-predictor or female-specific models were identified in 206 papers. Of these, 333 (56%) validations concerned nine models (five versions of Framingham, SCORE, Pooled Cohort Equations and QRISK). The median and pooled C statistics were comparable for sex-predictor and female-specific models. In 260 articles the added value of new predictors to an existing model was described, however in only 3 of these female-specific predictors (reproductive risk factors) were added.ConclusionsThere is an abundance of models for women in the general population. Female-specific and sex-predictor models have similar predictors and performance. Female-specific predictors are rarely included. Further research is needed to assess the added value of female-specific predictors to CVD models for women and provide physicians with a well-performing prediction model for women.